Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GABAPENTIN ENACARBIL Cause Product use issue? 15 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Product use issue have been filed in association with GABAPENTIN ENACARBIL (Horizant). This represents 0.8% of all adverse event reports for GABAPENTIN ENACARBIL.

15
Reports of Product use issue with GABAPENTIN ENACARBIL
0.8%
of all GABAPENTIN ENACARBIL reports
0
Deaths
4
Hospitalizations

How Dangerous Is Product use issue From GABAPENTIN ENACARBIL?

Of the 15 reports, 4 (26.7%) required hospitalization, and 1 (6.7%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GABAPENTIN ENACARBIL. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does GABAPENTIN ENACARBIL Cause?

Toxicity to various agents (592) Completed suicide (276) Off label use (158) Drug abuse (136) Drug ineffective (122) Cardio-respiratory arrest (109) Somnolence (73) Product use in unapproved indication (69) Dizziness (67) Accidental overdose (64)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which GABAPENTIN ENACARBIL Alternatives Have Lower Product use issue Risk?

GABAPENTIN ENACARBIL vs GADAVIST GABAPENTIN ENACARBIL vs GADOBENATE DIMEGLUMINE GABAPENTIN ENACARBIL vs GADOBUTROL GABAPENTIN ENACARBIL vs GADODIAMIDE GABAPENTIN ENACARBIL vs GADOLINIUM

Related Pages

GABAPENTIN ENACARBIL Full Profile All Product use issue Reports All Drugs Causing Product use issue GABAPENTIN ENACARBIL Demographics